| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | Aldesleukin ELISA Kit; IL 2 ELISA Kit; IL-2 ELISA Kit; IL2 ELISA Kit; IL2_HUMAN ELISA Kit; Interleukin 2 ELISA Kit; Interleukin-2 ELISA Kit; interleukin2 ELISA Kit; Involved in regulation of T cell clonal expansion ELISA Kit; Lymphokine ELISA Kit; OTTHUMP00000164090 ELISA Kit; POIL2 ELISA Kit; T Cell Growth Factor ELISA Kit; T-cell growth factor ELISA Kit; TCGF ELISA Kit |
| Assay Time | |
| Assay Type | |
| Detection Range | |
| Detection Wavelength | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | cell culture supernates, tissue homogenates |
| Sensitivity | |
| Species | |
| Target | |
| UniProt # |
Background
Interleukin 2 (IL2) is a biological molecule commonly studied in immunology research. It is commonly discussed as part of cytokine signaling that coordinates immune and inflammatory responses.
UniProt: P60568
Biological context
Researchers often monitor Interleukin 2 in cell culture supernates and tissue homogenates to better understand themes such as innate and adaptive immune responses, cytokine signaling networks, and host–pathogen interactions. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.
Interpreting changes in measured levels
Depending on sample matrix and study design, increases or decreases in Interleukin 2 may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, cytokines, chemokines, acute-phase proteins, and immune-cell activation markers) and by keeping pre-analytical variables consistent across groups.
Nomenclature
In publications and databases, Interleukin 2 may also appear under names such as Aldesleukin and IL 2. When comparing studies, confirm that the reported analyte refers to the same molecule and species context.
Why ELISA data are widely used
ELISA is a common approach for quantitative measurement of proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that Interleukin 2 participates in.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Особенности цитокиновой продукции у пациентов с бактериальной пневмонией, протекающей на фоне острой респираторной вирусной инфекции
ВК Парфенюк, НВ Бондарь,Российский медико-биологический вестник имени академика ИП Павлова,2025
IDO1 inhibition enhances CLDN18.2-CAR-T cell therapy in gastrointestinal cancers by overcoming kynurenine-mediated metabolic suppression in the tumor microenvironment
Z Wu, H Wang, Z Zheng, Y Lin, L Bian, H Geng,Journal of Translational Medicine,2025
Fusing a Novel Anti-CTLA-4 Nanobody to the IgG1 Fc Region Strengthens Its Ability to Induce CD8+ T Cell-Mediated Immune Responses Against Solid Tumors
T Li, J Yang, M Jiang, H Cui, X Yang,International Journal of Nanomedicine,2024
XAF1 is secreted from stressed tumor cells to activate T cell-mediated tumor surveillance via Lck-ERK signaling
J Ahn, SH Jang, S Jang, JH Yoon, MG Lee, SG Chi,Neoplasia,2025
A novel anti-CTLA-4 nanobody-IL12 fusion protein in combination with a dendritic cell/tumour fusion cell vaccine enhances the antitumour activity of CD8+ T cells in solid tumours
M Jiang, H Cui, T Li, X Yang, X Lu, A Liu,Journal of Nanobiotechnology,2024
Association of serum interleukin-2 with severity and prognosis in hospitalized patients with community-acquired pneumonia: a prospective cohort study
FM Zhu,Internal and emergency medicine,2024
Gut microbiome, T cell subsets, and cytokine analysis identify differential biomarkers in tuberculosis
Y Chai,/,2024
Association of serum interleukin-2 with severity and prognosis of community-acquired pneumonia: a prospective cohort study
FM Zhu,researchsquare,2023
Reduced NK Cell Cytotoxicity by Papillomatosis-Derived TGF-β Contributing to Low-Risk HPV Persistence in JORRP Patients
X Wu,Frontiers in immunology,2023
Intraoperative Assessment of Interleukin-2, Interleukin-6 and Tumor Necrosis Factor in Aqueous Humor of Diabetic and Non-diabetic Phacoemulsification SurgeryPatients Undergoing
R Yang,Iraqi National Journal of Medicine,2020
Assessing potential mechanisms of arsenic-induced skin lesions and cancers: Human and in vitro evidence
Zeng Q,Environmental Pollution,2020
miR-191 is involved in renal dysfunction in arsenic-exposed populations by regulating inflammatory response caused by arsenic from burning arsenic-contaminated coal
Y Xu, et al,Human & Experimental Toxicology,2019
The effect of silk peptide on immune system, A randomized, double-blind, placebo-controlled clinical trial
Jin-TaekHwang, et al,Journal of functional foods,2019
ZAP70 deficiency promotes reverse cholesterol transport through MAPK/ERK pathway in Jurkat cell
Liu J, et al,Molecular Immunology,2019
Induction of Sertoli cells from human fibroblasts by NR5A1 and GATA4
Jianlin Liang.et al,bioRxiv,2018
Elderly-onset hereditary pulmonary alveolar proteinosis and its cytokine profile
Masayuki Ito.et al,BMC Pulmonary Medicine,2017
Bedside-Friendly Prediction for Presence of Post-Myocardial lnfarction Systolic Dysfunction Using Multimarker Panel: Integrating Salivary Diagnostics into
Assareh A et al,Korean Circ J,2013